Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Dec 22;8(3):369-373.
doi: 10.1159/000455021. eCollection 2016 Sep-Dec.

Psoriasiform Diaper Rash Possibly Induced by Oral Propranolol in an 18-Month-Old Girl with Infantile Hemangioma

Raphaëlle Baggio  1 , Claire Le Treut  1 , Laure Darrieux  1 , Amélie Vareliette  2 , Gilles Safa  1
Affiliations
Case Reports

Psoriasiform Diaper Rash Possibly Induced by Oral Propranolol in an 18-Month-Old Girl with Infantile Hemangioma

Raphaëlle Baggio et al. Case Rep Dermatol. .

Abstract

Propranolol, a nonselective blocker of β-adrenergic receptors, has become the first-line treatment for complicated infantile hemangiomas. Therefore, its use in the pediatric population has expanded in recent years. In adults, β-blockers have been reported to be the most common causative agents for drug-induced psoriasis. In infants treated with propranolol for infantile hemangioma, the onset of psoriasiform diaper rash has not yet been reported. Here, to the best of our knowledge, we report the first case of psoriasiform diaper rash possibly induced by oral propranolol in an 18-month-old girl with no family history of psoriasis.

Keywords: Diaper rash; Drug induced; Infantile hemangioma; Propranolol; Psoriasiform eruption.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Psoriasiform diaper rash with well-demarcated erythematous scaly patches and plaque in the diaper area 6 weeks after beginning propranolol therapy.
Fig. 2
Fig. 2
Complete resolution of the psoriasiform diaper rash after 1 week of treatment with medium- to high-potency topical corticosteroids.
See this image and copyright information in PMC

References

    1. Darrow DH, Greene AK, Mancini AJ, Nopper AJ. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136:e1060–e1064. - PubMed
    1. Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735–746. - PubMed
    1. de Jager ME, De Jong EM, Evers AW, Van De Kerkhof PC, Seyger MM. The burden of childhood psoriasis. Pediatr Dermatol. 2011;28:736–737. - PubMed
    1. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633–636. - PubMed
    1. Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol. 2007;25:555–562. - PubMed

Publication types

LinkOut - more resources